Literature DB >> 8930131

The Oct-2 transcription factor.

D S Latchman1.   

Abstract

The Oct-2 transcription factor is a member of the POU (Pit-Oct-Unc) family of transcription factors and is expressed only in B lymphocytes and in neuronal cells but not in other cell types. The primary RNA transcript of the gene is subject to alternative splicing to yield different variants which can either activate or repress gene expression. The forms produced in B lymphocytes have a predominantly activating effect on gene expression whereas those produced in neuronal cells have a predominantly inhibitory effect and can repress the expression of both the herpes simplex virus immediate-early genes and the cellular tyrosine hydroxylase gene. Thus Oct-2 plays an important role in the regulation of cellular gene expression in both B cells and neuronal cells as well as in the control of viral latency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8930131     DOI: 10.1016/1357-2725(96)00050-7

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  11 in total

1.  Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Authors:  Mauricio L Nogueira; Victoria E H Wang; Dean Tantin; Phillip A Sharp; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

2.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

3.  PBMC transcriptomic responses to primary and secondary vaccination differ due to divergent lean growth and antibody titers in a pig model.

Authors:  Marcel Adler; Eduard Murani; Siriluck Ponsuksili; Klaus Wimmers
Journal:  Physiol Genomics       Date:  2015-07-14       Impact factor: 3.107

4.  Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1.

Authors:  Paul Shore; Wendy Dietrich; Lynn M Corcoran
Journal:  Nucleic Acids Res       Date:  2002-04-15       Impact factor: 16.971

5.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

Review 6.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

7.  The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.

Authors:  Amanda R Robinson; Swee Sen Kwek; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2012-02-09       Impact factor: 6.823

8.  OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia.

Authors:  Jasmine Lim; Anne Goriely; Gareth Dh Turner; Katherine A Ewen; Grete Krag Jacobsen; Niels Graem; Andrew Om Wilkie; Ewa Rajpert-De Meyts
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

9.  Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation.

Authors:  Ishtiaq Ahmad; Daniel C Hoessli; Evelyne Walker-Nasir; Saleem M Rafik; Abdul R Shakoori
Journal:  Nucleic Acids Res       Date:  2006-01-08       Impact factor: 16.971

10.  Alternative splicing of transcription factors' genes: beyond the increase of proteome diversity.

Authors:  David Talavera; Modesto Orozco; Xavier de la Cruz
Journal:  Comp Funct Genomics       Date:  2009-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.